Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples